You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Data day: Trial results deliver hope for prostate cancer patients

A pivotal Phase 3 trial has shown that a new combination treatment can significantly reduce the risk of death among prostate cancer patients by almost 33%.